Royalty Pharma plc Class A Ordinary Shares
€46.78
EUR
Last updated on --.
24h volume1.47M
24h highest47.6729 EUR
24h lowest45.1542 EUR
24h Price movement+1.02%


RPRX recent prices
24 Hours
+1.02%+€0.47209
30 days
+10.03%+€4.273
60 days
+17.55%+€6.999
90 days
+17.96%+€7.137
Key data
Previous close46.3142 EUR
Market cap20.22B EUR
Volume1.47M
P/E ratio28.430000
Dividend yield (TTM)0.03%
Dividend amount0.20208 EUR
Next ex-dividend date15 May 2026
Next payment date10 June 2026
EPS diluted (TTM)1.6080 EUR
Net income (FY)1.17B EUR
Revenue (FY)2.10B EUR
Last report date6 May 2026
About Royalty Pharma plc Class A Ordinary Shares
HeadquartersNEW YORK
Employees (FY)100.00
Revenue per employee (FY)20.99M EUR
Net income per employee (FY)11.69M EUR
Listed onNasdaq
RPRX conversion tables
| 0.5 RPRX | 23.39 EUR |
| 1 RPRX | 46.78 EUR |
| 5 RPRX | 233.93 EUR |
| 10 RPRX | 467.86 EUR |
| 0.5 EUR | 0.010687 RPRX |
| 1 EUR | 0.021374 RPRX |
| 5 EUR | 0.10687 RPRX |
| 10 EUR | 0.21374 RPRX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
RPRX is trading at €46.78, +1.02% over the last 24 hours. Track live moves on the price chart at the top of this page.
The RPRX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. RPRX is currently trading at €46.78, +1.02% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on RPRX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. RPRX's P/E ratio is currently 28.430000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from RPRX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against RPRX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Royalty Pharma plc Class A Ordinary Shares's market cap is currently 20.22B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.47M
24h highest47.6729 EUR
24h lowest45.1542 EUR
24h Price movement+1.02%


Start trade with RPRX Perpetual
Sign up to trade
















